GlassScriptPhysician profile
Nicole Siobhan Patching
NPI 1134612658
$575.99
in general payments reported to CMS, 2019-2025
10 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Obesity Medicine (Family Medicine) provider received nationally (typical 2025 total: $183).
See the full distribution for Obesity Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $215 · 2023: $63.08 · 2024: $115 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303 · Education: $58.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $302.86 |
| Education | $58.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $124.98 | 2025 | Airsupra |
| Rhythm Pharmaceuticals, INC. | $121.08 | 2023-2025 | Imcivree |
| Abbvie INC. | $75.98 | 2022-2024 | |
| Tactile Systems Technology INC | $71.86 | 2022 | |
| Collegium Pharmaceutical, INC. | $54.41 | 2022 | |
| Grt US Holding, INC. | $45.00 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $27.31 | 2024 | Rexulti |
| Merck Sharp & Dohme LLC | $18.85 | 2024 | Gardasil, Vaxelis, Gardasil 9 |
| Sanofi-Aventis U.S. LLC | $18.49 | 2024 | |
| Novo Nordisk INC | $18.03 | 2024 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Patching listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.